HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Oturai Selected Research

Peter Oturai Research Topics

Disease

10Neoplasms (Cancer)
03/2024 - 10/2020
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2015
4Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2020 - 08/2012
3Insulin Resistance
10/2022 - 03/2014
3Lymphedema (Milroy Disease)
12/2019 - 01/2016
2Fabry Disease (Fabry's Disease)
01/2022 - 01/2019
2Inflammation (Inflammations)
01/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2021 - 11/2017
2Breast Cancer Lymphedema
01/2018 - 01/2016
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024
1Carcinoma (Carcinomatosis)
01/2024
1Urologic Neoplasms (Urological Cancer)
01/2024
1Anemia
10/2023
1Weight Loss (Weight Reduction)
10/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2023
1Multiple Endocrine Neoplasia Type 1
01/2023
1Hypokalemia
01/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2022
1Testicular Neoplasms (Testicular Cancer)
10/2022
1Xerostomia
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Hemolysis
01/2021
1End Stage Liver Disease
01/2020
1Hypotension (Low Blood Pressure)
01/2020
1Acute Kidney Injury (Acute Renal Failure)
06/2019
1Bone Resorption
01/2019
1Osteoporosis
01/2018
1Infections
01/2018
1Hyperglycemia
01/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017
1Neuroendocrine Carcinoma
01/2016
1Atherosclerosis
12/2015
1Atherosclerotic Plaque (Atheroma)
12/2015
1Colonic Neoplasms (Colon Cancer)
01/2015
1Overweight
03/2014
1Obesity
03/2014
1Mental Disorders (Mental Disorder)
03/2014
1Weight Gain
03/2014
1Body Weight (Weight, Body)
03/2014
1Type 2 Diabetes Mellitus (MODY)
03/2014

Drug/Important Bio-Agent (IBA)

964Cu-DOTATATEIBA
01/2023 - 06/2015
8Somatostatin Receptors (Somatostatin Receptor)IBA
01/2023 - 12/2015
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2021 - 01/2021
2Ga(III)-DOTATOCIBA
03/2017 - 12/2015
1Temozolomide (Temodar)FDA LinkGeneric
03/2024
1Fluorouracil (Carac)FDA LinkGeneric
03/2024
1Carboplatin (JM8)FDA LinkGeneric
03/2024
1Etoposide (VP 16)FDA LinkGeneric
03/2024
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024
1PlatinumIBA
01/2024
1Carbon MonoxideIBA
10/2023
1Sodium-Glucose Transport ProteinsIBA
10/2023
1SodiumIBA
10/2023
1Sodium-Glucose Transporter 2 InhibitorsIBA
10/2023
1PotassiumIBA
01/2023
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
10/2022
1Testosterone (Sustanon)FDA Link
10/2022
1EnzymesIBA
01/2022
1GalactosidasesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Urea (Carbamide)FDA LinkGeneric
01/2021
1Chromogranin AIBA
10/2020
1Felodipine (Agon)FDA LinkGeneric
01/2020
1Tacrolimus (Prograf)FDA LinkGeneric
01/2020
1OsteocalcinIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1CalciumIBA
01/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2018
1taxaneIBA
01/2018
1Insulin (Novolin)FDA Link
01/2018
1C-Reactive ProteinIBA
01/2018
1technetium 99m hydroxyethylene-diphosphonateIBA
11/2017
1LeptinIBA
01/2017
1AdiponectinIBA
01/2017
1AdipokinesIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2016
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2015
1pegfilgrastim (Neulasta)FDA Link
01/2015
1Olanzapine (Zyprexa)FDA Link
03/2014
1Clozapine (Clozaril)FDA LinkGeneric
03/2014
1LiraglutideFDA Link
03/2014
1LipidsIBA
03/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
03/2014
1Antipsychotic Agents (Antipsychotics)IBA
03/2014
1IncretinsIBA
03/2014
1Hormones (Hormone)IBA
03/2014

Therapy/Procedure

5Drug Therapy (Chemotherapy)
03/2024 - 01/2015
4Adjuvant Chemotherapy
01/2020 - 01/2015
3Therapeutics
10/2022 - 01/2021
2Renal Dialysis (Hemodialysis)
10/2023 - 01/2021
2Lymph Node Excision (Lymph Node Dissection)
01/2018 - 01/2016
1Drug Tapering
01/2022
1Radiotherapy
01/2022
1Aftercare (After-Treatment)
01/2022
1Blood Transfusion (Blood Transfusions)
01/2020
1Cardiopulmonary Bypass (Heart-Lung Bypass)
06/2019
1Enzyme Replacement Therapy
01/2019
1Activities of Daily Living (ADL)
01/2016